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Aims To investigate if gender bias is present in today’s setting of an early invasive strategy for patients with acute coronary
syndrome in Denmark (population 5 million).
Methods
and results
We identified all patients admitted to Danish hospitals with acute coronary syndrome in 2005–07 (9561 women and
16 406 men). Cox proportional hazard models were used to estimate the gender differences in coronary angiography
(CAG) rate and subsequent revascularization rate within 60 days of admission. Significantly less women received
CAG (cumulative incidence 64% for women vs. 78% for men, P, 0.05), with a hazard ratio (HR) of 0.68 (95% CI
0.65–0.70, P, 0.0001) compared with men. The difference was narrowed after adjustment for age and comorbidity,
but still highly significant (HR 0.82, 95% CI 0.80–0.85, P, 0.0001). Revascularization after CAG was less likely in
women with an HR of 0.68 (95% CI 0.66–0.71, P, 0.0001) compared with men. More women (22%) than men
(10%) (P, 0.0001) had no significant stenosis on their coronary angiogram. However, after adjustment for the
number of significant stenoses, age, and comorbidity women were still less likely to be revascularized (HR 0.91,
95% CI 0.87–0.95, P, 0.0001).
Conclusion Women with ACS are approached in a much less aggressively invasive way and receive less interventional treatment
than men even after adjusting for differences in comorbidity and number of significant stenoses.
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Introduction
Gender disparity in cardiac diagnosis and treatment has been inves-
tigated thoroughly since Ayanian first described this phenomenon.
In 1991, he observed that women were less likely than men to
undergo diagnostic coronary angiography (CAG) and coronary
revascularization.1 However, data have been inconsistent, with
some studies contradicting the presence of a gender bias,2,3 and
others supporting it4,5—thus, the debate is ongoing.6,7
Gender differences in the invasive management of acute coronary
syndrome (ACS) have been described in both observational and ran-
domized clinical studies.8 –10 It has been shown that women are less
likely to undergo reperfusion therapy after ACS.10,11 Some of the
difference has been attributed only to differences in age and comor-
bidity with no gender difference when these factors were taken into
account.12 It has also been suggested that differences in coronary
artery disease (CAD) could account for some of the difference,
and this has been shown in selected populations.13,14
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A reason for possible differences in the invasive approach to men
and women with ACS could be that controversy exists with respect
to the benefit of revascularization treatment in women. Thus, sub-
group analysis in the FRISC 2 (Fragmin and Fast Revascularisation
During Instability in Coronary Artery Disease) trial15 and RITA 3
(The Randomized Intervention Trial of unstable Angina) trial16
showed that an invasive strategy may be associated with an increased
risk of death or myocardial infarction (MI) in women compared with
a conservative strategy. In contrast, the results of the TACTICS-TIMI
18 (Treat angina with Aggrastat and determine Cost of Therapy with
an Invasive or Conservative Strategy-Thrombolysis in Myocardial
Infarction 18) trial17 supported that both women and men had
improved outcomes, and women with a high-risk profile had the
most benefit from revascularization.
Supporting the results of TACTICS-TIMI 18 a recent meta analy-
sis of randomized clinical trials (RCT), comparing an early invasive
strategy with a conservative treatment strategy in patients with
non-ST-segment elevation myocardial infarction (non-STEMI) and
unstable angina pectoris (UAP), found that men and high-risk
women benefit from an early invasive strategy.18
Currently available data on invasive treatment in ACS and the
gender issue are limited to only RCTs or from registries from an
earlier period, when patients were generally treated with
thrombolysis.
In Denmark, current guidelines recommend a very early invasive
strategy for all patients with STEMI following the results of the
DANAMI 2 trial,19 and an early invasive strategy for non-STEMI
patients following the results of the FRISC 2 trial.15
To examine if a gender difference exists with respect to invasive
treatment of ACS in the present real-world setting, and to deter-
mine at which stage and which factors might influence the choice
of strategy, we used nationwide registries to investigate all admis-
sions with ACS in Denmark (5.4 million inhabitants) in 2005–2007.
We included data on revascularization, coronary angiograms, mor-
bidity, type of admitting hospital, and the number of hospitals each
patient was transferred to during their hospital stay.
Methods
Study population
The study was designed as a prospective observational cohort study of
all patients in Denmark admitted to a hospital with ACS in 2005–07.
All residents in Denmark have a unique and permanent personal civil
registration number, which allows linkage between nationwide regis-
tries on an individual level.
Information on admissions and comorbidity was obtained from the
Danish National Patient Registry, which holds information on all admis-
sions to all Danish hospitals since 1978.
Each admission is registered by one primary diagnosis and, if appro-
priate, one or more secondary diagnoses according to the Inter-
national Classification of Diseases (ICD)—before 1994, the 8th
revision (ICD-8) and after 1994 the 10th revision (ICD-10). The diag-
noses registered in the Danish National Patient Registry are the final
discharge diagnoses.
We identified all patients 30–90 years old admitted with MI or UAP
as the primary discharge diagnosis (ICD-10, codes I20-I22). Day of
admission was 1 January 2005 to 31 December 2007. To study first
admission with ACS, we excluded all patients with a previous diagnosis
of MI 1978–93 (Using ICD-8 code 410), or ACS since 1994. The
definition of MI and UAP in Denmark follow the guidelines of the
European Society of Cardiology. All patients discharged on the day
of admission were excluded to ensure that diagnosis was based on
reliable observation and sufficient blood tests. Patients not surviving
the day of admission were excluded because of insufficient time to
begin treatment and possible problems with assertion of diagnosis.5,20
The diagnosis of acute MI in the registry has been validated by com-
parison with the results from the MONICA database.21 The sensitivity
and specificity are 90–95%. A recent study found a positive predictive
value of 92.4% for the diagnosis of MI and 80.1% for ACS; this was
with the same inclusion criteria as our study, but without applying
the strict exclusion criteria we have used.22 To ensure the robustness
of the results we did sensitivity analyses on only those patients with
an MI.
In a recent Danish study of 132 290 persons, the incidence rate of
ACS admissions by direct observation differed insignificantly from
the incidence rate of ACS found in the National Patient Registry.23
Information on the patient’s vital status (alive or date of death) was
obtained from The Danish Civil Registration System, where all
persons residing in Denmark are registered from birth or time of
immigration.
Explanatory variables
Age
The age of each patient was categorized into 10 year intervals and was
used as categorical variables.
Extent of coronary artery disease
Information on the extent of CAD among patients examined by CAG
was obtained in the Danish Heart Registry (www.dhreg.dk),24 which
includes all invasive examinations and procedures performed at
Danish hospitals since the year 2000. A significant lesion was defined
as at least 50% stenosis in a major epicardial vessel or coronary
artery bypass graft. The procedures and examination results were vali-
dated by comparison of a stratified random sample of 200 procedures
in the registry (50 CAG, 50 PCI, 50 CABG and 50 valve replacements)
with local registries and written patient records. All 200 procedures
could be confirmed to have taken place, and the result of the 50 cor-
onary angiographies was found to be in accordance with the patient’s
records.25
Comorbidity
Primary and secondary diagnoses, both at the index admission and at
admissions up to 1 year before the index admission, were used to
define comorbidity.26 Diagnoses of congestive heart failure, cardio-
genic shock, arrhythmia, and pulmonary oedema gave indications of
the severity of the heart disease, while diagnoses of malignancy, dia-
betes with complications, cerebrovascular disease, acute renal failure,
and chronic renal failure indicated comorbidity. This method is an
extension of the Ontario MI mortality prediction rule27 with trans-
lation to ICD-10 codes validated by So et al.,28 hence this ICD-10
coding was used. As a proxy for smoking, chronic obstructive pulmon-
ary disease was included independently in the model (ICD-10; J40–J44,
J47). Sex, age, admission year, and each of the risk factors were
retained in the model regardless of their significance level.
Regional variation
The Danish Society of Cardiology has nationwide guidelines on the
treatment of ACS.
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Patients were categorized into two groups according to whether
they lived in a county with a hospital performing revascularization
procedures.
Previous revascularization within 5 years of index event was
recorded for each patient, as this might affect the decision to initiate
an invasive examination.
Outcomes
We estimated the effect of gender on the execution of CAG and on
subsequent revascularization (time to either PCI or CABG) for
those having had a CAG performed within 60 days of admission.
A 60-day observation period was used to include as many examin-
ations and procedures as possible and, at the same time, to avoid
angiographies made because of reinfarction. To choose the obser-
vation period, a separate sensitivity analysis was performed. We ana-
lysed proportions revascularized within 30, 60, 90, 120, 150, and 180
days. We found that the majority of patients were revascularized
within 60 days, which was therefore chosen as the observation period.
We estimated the mortality rate in the 60 days after the event using
the Kaplan–Meier estimator, averaging the estimated survival for both
genders to a 70-year-old person.
Since differences in mortality could potentially influence the rate of
procedures we used a competing risks model to analyse the data as
described by Andersen et al.29 Cumulative incidence curves were
calculated for the incidence of CAG in the whole population and of
revascularization in the CAG population, and the cumulative incidence
at 60 days was read from the curves.
Timing of procedures
Differences in the presentation of the disease could lead to differences
in the timing of the invasive examination and subsequent treatment.
We, therefore, performed a stratified analysis of procedures, dividing
them into acute, being on the day of admission or the day after, and
sub-acute from Day 2 until Day 60.
Statistical analysis
Continuous variables are presented as mean+standard deviation (SD)
for characteristics with appropriately near-symmetrical distributions or
as median (interquartile range). Discrete data are presented as fre-
quencies and percentages. Differences between sexes in the baseline
characteristics were evaluated using Pearson x2-test for categorical
variables and the non-parametric Mann–Whitney U-test for continu-
ous variables.
Cumulative incidence curves were estimated in a competing risks
model with the SAS-macro developed by Rosthoj et al.30
Gender differences in outcome were estimated using Cox pro-
portional hazards regression, both uni- and multivariable.
Outcome variables were CAG in the whole population, and revas-
cularization in the group who had CAG performed. In the multivariable
analysis age, year of admission, place of residence, prior PCI or CABG
(within 5 years of index event), and comorbidity were included in the
model along with sex. Model assumptions—linearity, proportional
hazards, and interactions—were tested and found valid unless other-
wise indicated. All hypothesis tests had a 0.05 significance level. All
tests were two-sided.
As a sensitivity analysis, we used propensity score analysis to identify
a set of cases (women) and controls (men) who were matched on age,
comorbidity, admission year, admission diagnosis, and previous revas-
cularization. A propensity score was quantified by multivariable logistic
regression. The C statistic was 0.65, indicating a reasonable
discriminative power of the model. A Greedy matching macro (by
Lori S. Parsons, accessed 14 April 2009, at http://www2.sas.com/
proceedings/sugi26/p214-26.pdf) was used to match each case to
one control. A multivariable-adjusted Cox-model was fitted including
the propensity score.
All analyses were performed with SAS statistical software package
version 9.13 (SAS Institute, Inc., Cary, NC, USA).
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Table 1 Baseline characteristics of patients
Women Men
Number (%) 9132 (37.8) 15 820 (62.2)
Mean age in years (SD) 71.1 (12.7) 65.1 (12.6)*
Place of residence, n (%)
County with invasive hospital 3662 (40) 6262 (40)
County without invasive hospital 5470 (60) 9558 (60)
Length of admission period
Median time in days (Q1–Q3) 6 (4–11) 5 (4–10)*
Preceding admissions, n (%)
Admission 1 week prior 1043 (11) 1503 (10)*
Hospital category of first admission, n (%)*
Hospital without invasive
facilities
4923 (54) 7822 (49)
Hospital with CAG facilities 2068 (23) 3582 (23)
Hospital with invasive centre 2141 (23) 4416 (28)
Number of hospitals during admission period, n (%)*
1 hospital 5284 (58) 7806 (49)
2 hospitals 2031 (22) 4365 (28)
3 hospitals 1615 (18) 3257 (21)
More than 3 hospitals 202 (2) 392 (2)
Previous revascularization, n (%)
Revascularization the last 5 years 240 (3) 643 (4)*
Comorbidity, n (%)
Congestive heart failure 1066 (12) 1442 (9)*
Pulmonary oedema 98 (1) 101 (1)*
Shock 59 (1) 87 (1)
Arrhythmia 1224 (13) 1685 (11)*
Cerebrovascular disease 531 (6) 698 (4)*
Chronic obstructive pulmonary
disease
741 (8) 743 (5)*
Diabetes with complications 522 (6) 709 (4)*
Chronic renal failure 128 (1) 278 (2)*
Acute renal failure 73 (1) 153 (1)
Malignancy 231 (3) 423 (3)
Examinations, n (%)
CAG within 1 day 2592 (28) 6276 (40)*
CAG within 60 days 5845 (64) 12 417 (78)*
Discharge diagnosis, n (%)
Acute myocardial infarction 7532 (82) 13 305 (84)*
Unstable angina pectoris 1600 (18) 2515 (16)*
*Statistically significant difference between genders (P-value ,0.05).
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Ethics
The Danish National Board of Health, the Danish Data Protection
Agency, and the Board of the Danish Heart Registry all approved
the project, which was carried out in accordance with current rules
of ethics and legislature. Register-based studies do not require
ethical approval in Denmark.
Results
In Denmark 25 967 patients were admitted with ACS from
1 January 2005 to 31 December 2007. Among all the patients,
40% of the women and 62% of the men were finally revascularized.
In all 1015 patients were excluded, 515 were discharged on the day
of admission, and 500 patients did not survive the day of admission.
Thus, 24 952 patients had a hospital stay of at least one day, and a
discharge diagnosis of MI or UAP. Among these patients, CAG was
undertaken in 5845 of 9132 women (64%) and in 12 416 of 15 818
men (78%) during the 2 months of follow-up, P, 0.0001 (28 vs.
40% in the acute phase P, 0.0001).
Baseline characteristics
Baseline characteristics of the study population are shown in
Table 1. Mean age of women was 6 years higher than that of
men. Men were more often than women diagnosed with an MI
(84 vs. 82%). Comorbidities including congestive heart failure,
arrhythmia, chronic obstructive pulmonary disease, and diabetes
with complications were significantly more frequent in women
than in men. There was no difference in place of residence.
Women were more often admitted directly to hospitals without
invasive facilities (54 vs. 49%). Furthermore, women were less
likely to have been to more than one hospital, i.e. transferral to
a second (or third) centre was less likely (58 vs. 49%). Figure 1
shows estimated mortality in the first 60 days after admission for
a 70-year-old male and for a 70-year-old female (P ¼ 0.32).
Coronary angiography
Among the 18 262 patients examined with CAG, women were
more frequently without significant lesions at CAG (Table 2) (22
vs. 10% in men, P, 0.0001), even if restricted to patients with a
diagnosis of confirmed MI (18.1 vs. 7.6% P, 0.0001). Accordingly,
men more often had 1-, 2-, and 3-vessel disease (Table 2). The
probability in the competing risk model of invasive examination
within 60 days was 0.64 for women and 0.78 for men. (Figure 2).
In the univariable Cox-model, the hazard ratio (HR) of having a
CAG performed was 0.68 (95% CI, 0.66–0.70, P, 0.0001) for
women compared with men (Table 3). When including the age
groups in the Cox-model, HR was 0.83 (95% CI, 0.80–0.85, P,
0.0001) for women of having a CAG performed. After including
all variables in the Cox-model, the HR did not change appreciably
(Table 3). Both in the acute and sub-acute phases, women were
less likely to receive CAG. The results were similar when restrict-
ing the analysis to patients with confirmed MI (data not shown).
Figure 1 Estimated mortality curves for a 70-year-old woman/
man in the first 60 days among patients admitted with acute
coronary syndrome.
Figure 2 Cumulative incidence curves showing gender differ-
ences in invasive examination rate in the first 60 days among
patients admitted with acute coronary syndrome.
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Table 2 Result of coronary angiography and
subsequent invasive treatment
Women Men
Number of patients having CAG
performed (%)
5845 (32) 12 417 (68)
Extent of disease at angiography, n (%)a (*)
No significant stenosis 1298 (22) 1181 (10)
1 vessel disease 2281 (39) 5187 (42)
2 vessel disease 1032 (18) 2890 (23)
3 vessel disease 926 (16) 2487 (20)
Missing result 308 (5) 672 (5)
Revascularization, n (%)
Revascularization within 60 days 3861 (66) 10 104 (81*)
PCI within 60 days 3496 (60) 8846 (71*)
CABG within 60 days 434 (7) 1538 (12*)
CAG, coronary angiography; PCI, percutaneous coronary intervention; CABG,
coronary artery bypass graft.
aDiseased vessel defined as at least 50% stenosis in a major epicardial vessel or
coronary artery bypass graft.
*Statistically significant difference between genders (P-value ,0.05).
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In the propensity score matched analysis 8497 women were
matched one-to-one to 8497 men. The propensity adjusted
Cox-model yielded an HR of 0.84 (95% CI 0.81–0.87, P,
0.0001) of receiving CAG if you were a woman in comparison
to a similar man.
Revascularization
Of the patients examined with CAG, 66% of women (3861/5845)
and 81% of men (10 104/12 417) received revascularization, P,
0.0001. The probability in the competing risk model of revasculariza-
tion within 60 days was 0.67 for women and 0.81 for men (Figure 3).
In the univariable Cox-model, the HR of revascularization was
0.68 (95% CI, 0.66–0.71, P, 0.0001) for women (Table 4). This
did not change appreciably after inclusion of age groups and the
other variables. However, when the result of the CAG was
included in the model as an indicator of severity of CAD, there
was less difference between sexes, but still significantly less invasive
revascularizations of women (HR 0.91, 95% CI 0.87–0.95, P,
0.0001). The propensity adjusted Cox-model, with the result of
the CAG included, yielded an HR of 0.92 (95% CI 0.88–0.96,
,0.0001) of receiving revascularization if you were a woman.
When investigating PCI and CABG separately, the HRs showed a
similar pattern, with CABG having the largest difference between
sexes (Table 4). Time from admission to invasive treatment with
PCI was similar in men and women. Restricting the analyses to
patients with confirmed MI yielded similar results (data not shown).
Discussion
We demonstrated, at a nationwide level, that significantly fewer
women with ACS are revascularized even after correcting for
baseline differences and differences in mortality after ACS. A less
aggressive invasive diagnostic approach in women accounted for
much of the difference in invasive treatment. Furthermore, the
difference in invasive treatment of women was to some extent
explained by less severe CAD. Importantly, the results did not
differ when restricting the analysis to the 83% of the patients
with confirmed MI.
The result of the propensity score matched subpopulation was
in accordance with our findings on the whole population.
The Danish recommendations for the treatment of ACS follow
the European guidelines, and during the study period there were
no differences in the recommendations for women and men.
These recommendations were clear, despite controversies existing
with respect to the benefit of invasive treatment in women.15,16
The gender difference in the rate of CAG could not be
explained by other variables available in our study. The difference
between men and women was present, in both the acute phase
and the non-acute phase of ACS, although a larger difference
was present in the acute phase. We can only speculate as to the
reasons, but a different symptom presentation in women31 and a
higher proportion of ST-elevation MI in men14 could contribute
to the observed difference. Data on these matters are not cur-
rently available in the registries.
The gender difference in rate of invasive revascularization among
patients examined with CAG could largely be explained by differ-
ences in the extent of CAD found at the CAG. Nevertheless, a sig-
nificant difference still persisted between the sexes, when taking
this information into account.
Differences in the size of coronary arteries, where smaller diam-
eter vessels in women could lead to technical difficulties in the
procedures might explain some of the difference.
Our findings are in accordance with previous findings of a
gender bias in the invasive treatment of ACS.6,7,10,13,14 We found
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Table 3 Successively adjusted relationship between gender and coronary angiography in patients admitted with acute
coronary syndrome
Outcome measure Observation time (days) Women vs. men hazard ratio (95% confidence interval)
Model 1a Model 2b Model 3c
CAG 60 0.68 (0.65–0.70) 0.83 (0.80–0.85) 0.82 (0.80–0.85)
CAG acute 1 0.66 (0.63–0.69) 0.78 (0.74–0.82) 0.78 (0.75–0.82)
CAG non-acute 59 0.69 (0.66–0.72) 0.87 (0.83–0.91) 0.86 (0.82–0.89)
CAG, coronary angiography.
aUnadjusted.
bAdjusted for age group.
cAdjusted for age group, year of admission, place of residence, previous revascularization and comorbidity (all as categorical variables).
Figure 3 Cumulative incidence curves showing gender differ-
ences in revascularization rate in the first 60 days among patients
undergoing coronary angiography.
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differences, however, in both the CAG and revascularization rates.
Even after taking the differences in the number of affected vessels
into account the differences persisted both in PCI and CABG rates,
something not previously shown.
Strengths and limitations
The contemporary data and the completeness of the registries give
valuable information on the management strategies of ACS in the
present clinical setting, and the findings point towards areas
needing our attention. This study was based on complete and
nationwide data. The data covered the entire population of
Denmark, independent of race, socioeconomic status, age or par-
ticipation in health-insurance programmes. Therefore, the risk of
selection-bias was minimized, and the study included citizens
both in and outside the labour market. Reporting to the Danish
Heart Registry was mandatory by a directive issued by the
Danish Board of Health for all hospitals performing the pro-
cedures, both public and private, which strengthens the complete-
ness of the data. The patients had a length of stay of at least 1 day
and left with a discharge diagnosis of ACS, thus adding to the val-
idity of the diagnosis. No gender differences were observed in the
number of excluded patients.
The main limitation was inherent in the observational nature of
the study. Other limitations to our analysis that warrant consider-
ation were the differences between men and women in the clinical
presentation of ACS on which we had little information.32 We had
no information on key clinical variables, such as ECG changes on
presentation, elevation in biomarkers, and medication before and
after the event. The diagnosis of UAP had not been validated in
the registries to the same extent as the MI diagnosis, but we
found that patients with UAP underwent similar diagnostic investi-
gations as did patients with MI. The sensitivity analysis of data from
only MI patients yielded the same overall results.
Conclusion and implications
Our study showed that the gender differences in invasive treat-
ment after ACS can be attributed to two things: women were
less likely to undergo CAG because of factors associated with
gender independently of age and comorbidity, and differences in
coronary artery disease account for most, but not all, of the differ-
ences in revascularization rate between men and women who had
a CAG. Hence, gender is an issue in the choice of strategy, mostly
in the choice of performing the CAG and, to a minor degree, in the
subsequent execution of mechanical revascularization.
Thus, more focus on the sex as an independent issue in the inva-
sive treatment of ACS is warranted, and in particular we rec-
ommend that registries closely follow the pattern of angiography
and revascularization.
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